Evidence map›Paper›PMID 31057322›Full record

ArticleMolecular vision2019

Investigating a downstream gene of

Ye Lu, Diana Zhou, Hong Lu, Fuyi Xu, Junming Yue, Jianping Tong, Lu Lu

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Molecular vision, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in neuroscience · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ye LuDepartment of Ophthalmology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
Diana ZhouDepartment of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN.
Hong LuDepartment of Ophthalmology, Nantong Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Fuyi XuDepartment of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN.
Junming YueDepartment of Pathology, University of Tennessee Health Science Center, Memphis, TN.
Jianping TongDepartment of Ophthalmology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
Lu LuDepartment of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN.
University of Tennessee Health Science Center · US

Funding

Genetic Modulators of GlaucomaR01EY021200 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JABLONSKI, MONICA M · 2011 to 2022
$3.2M
NEI NIH HHS R01 EY021200
6 · The paper itself

Abstract

Purpose: Glaucoma is characterized by optic nerve damage and retinal ganglion cell loss. The glycoprotein neuromedin B-associated ( Methods: Retinal gene expression data for the BXD recombinant inbred (RI) strains (n=75) have previously been generated in our laboratory for a glaucoma study, and these data were used for genetic and bioinformatics analysis. Expression quantitative trait locus (eQTL) mapping and genetic correlation methods were used to identify a gene downstream of Results: The level of Conclusions: These results suggest that

Indexed as

Gene Regulatory NetworksAnimalsApoptosisComputational BiologyDisease Models, AnimalEye ProteinsGene Expression ProfilingGene Expression RegulationGene OntologyGlaucomaGlycoproteinsHumansMembrane GlycoproteinsMiceMice, TransgenicMitochondriaEye ProteinsGlycoproteinsGpnmb protein, mouseMembrane Glycoproteinsteleocalcin

Identifiers

PMID31057322
PMCPMC6478243
OpenAlexW2955634009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.